Description
Corlift 2.5 mg Tablet contains Vericiguat, an oral soluble guanylate cyclase stimulator used in the management of chronic heart failure with reduced ejection fraction (HFrEF). It is indicated to lower the risk of cardiovascular death and heart failure hospitalization in adult patients who recently experienced worsening heart failure. Vericiguat enhances nitric oxide signaling, improving vascular tone and cardiac function.
.webp)
Change Language